# Ondansetron

## Zofran inj. 8mg/4mL\(限麻醉組套\)

| 藥物代碼 | IZOF |
| :--- | :--- |
| 適應症 | Prevention or treatment of nausea and vomiting caused by surgery, chemotherapy or radiation therapy. |
| 副作用 | CommonGastrointestinal: Constipation \(11% \), Diarrhea \(adults, 16%; pediatrics, 2%\), Xerostomia \(5% \)Hepatic: Increased liver enzymes \(17% \)Neurologic: Headache \(17% \)Other: Fever \(2% to 8% \)SeriousCardiovascular: Atrial fibrillation, Electrocardiogram abnormal, Prolonged QT interval, Torsades de pointesNeurologic: Oculogyric crisisOther: Serotonin syndrome |
| 禁忌 | Hypersensitivity to ondansetron or any component of the formulation; concomitant use with apomorphine |
| 藥物保存方式 | 儲存於30℃以下,避光 |
| 用法用量 | Prevention of nausea and vomiting caused by surgery: single dose of 4 mg IM or slowly IV \(more than 30 seconds\). Treatment of nausea and vomiting caused by surgery: A single dose of 4 mg is recommended for most patients, administered IM or slowly IV. increased to 8 mg if necessary. Children from 1 month to 17 years: A clinical trial in children under 2-years-old has not been conducted. slow IV injection \(more than 30 seconds\) before, during or after induction of anesthesia, 0.1 mg/kg, and up to 4 mg. Nausea and vomiting due to chemotherapy or radiation therapy: adult: The recommended dose is 8 mg IV or IM before treatment. After 24 hours, oral medication is recommended to prevent delayed or prolonged vomiting. a single 8 mg dose by slow IV or IM immediately before chemotherapy. High than 8 mg of a dose can only be administered by IV infusion after dilution with 50 to 100 ml of normal saline or other compatible infusion solutions, and the infusion time should be more than 15 minutes. A single dose should not exceed 16 mg, cause QT interval prolongation is dose-dependent. For high emetic chemotherapy, slow IV injection \(more than 30 seconds\) or IM 8 mg before chemotherapy, and next two doses of 8 mg every 2 to 4 hours or continuous infusion \(1 mg/hour\) for a maximum of 24 hours. Children over 6 months and adolescents: Medication according to body surface area or body weight. ZOFRAN should be administered as a single intravenous injection of 5 mg / m2 immediately before chemotherapy. The intravenous injection dose should not exceed 8 mg. It should be administered by intravenous infusion for a period of not less than 15 minutes. Oral medication can begin after 12 hours and can last up to 5 days. The intravenous dose should not exceed 8 mg. Do not exceed the adult dose. BSA &lt;0.6 m2: on day 1, 5 mg / m2 intravenously and 2 mg syrup given 12 hours later, 2 mg syrup every 12 hours on 2 to 6 days. BSA&gt;= 0.6 m: on day 1, 5 mg / m2 intravenously and 4 mg syrup given 12 hours later, 4 mg syrup every 12 hours on 2 to 6 days. ZOFRAN should be administered as a single dose of 0.15 mg/kg intravenously just before chemotherapy, and the intravenous dose should not exceed 8 mg. On the first day, two additional doses can be injected intravenously, with each dose separated by 4 hours. The dose should be given by intravenous infusion for a period of not less than 15 minutes. The total daily dose must not exceed the adult dose. Oral medication can begin after 12 hours and can last up to 5 days. &lt;= 10 kg: on day 1,up to 3 doses of 0.15 mg/kg every 4 hours. on days 2 to 6, 2 mg of syrup every 12 hours. &gt; 10 kg: on day 1, up to 3 doses of 0.15 mg/kg every 4 hours. on days 2 to 6, 4 mg of syrup every 12 hours. |
| 肝功能異常 | 需 調 整 劑 量  \[仿單\]中度或重度肝功能不全者的ondansetron清除率顯著降低，血清半衰期顯著延長。 用於這類病人時，靜脈注射或口服的每日總劑量不可超過8毫克。 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | Human \(and animal\) data suggest risk |
| 附帶說明 | \[仿單\]卓弗蘭用於孕婦的安全性目前尚未獲得證實。在大鼠和兔子的生殖試驗中，於器官生成期間分別給予依據體表面積約相當6和24倍於人體最大建議口服劑量每天24毫克的ondansetron時，未觀察到傷害胎兒的證據。 然而，由於不一定能自動物試驗預測人體反應，不建議於懷孕期間使用ondansetron 。有關懷孕期間使用ondansetron的安全性資料有限，且取自藥物流行病學試驗的發現並不一致。 上市後報告中描述了懷孕期間使用Zofran的先天畸形病例； 然而，這些報告並不足以建立因果關係。 |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | \[仿單\]目前不清楚Zofran是否會進入人體乳汁。 目前並無關於Zofran影響哺乳嬰兒或Zofran影響乳汁生成的資料。 然而，已知ondansetron會進入哺乳動物\(大鼠\)的乳汁。 因此，建議接受ondansetron的母親不應哺育嬰兒。 |
| 注射劑給藥建議途徑 | IM, IVD, IVPUSH |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D10W】 可選 仿單建議  【D5W】 可選 仿單建議  【IKCL2】 可選 仿單建議  【IKCL5S】 可選 仿單建議  【L/R】 可選 仿單建議  【N/S】 可選 仿單建議 |
| IVP 用法建議 | IV bolus over no less than 30 seconds, preferably over 2 to 5 minutes. |
| IVD 用法建議 | Dilute 8mg \(or 16 mg\) dose in 50 mL \(or 100mL\) of compatible solutions and infuse dose over 15 minutes. |
| 注意事項 | 為保持良好的製劑狀態， 靜脈輸注液應於輸注前才調配， 並保持在適當的無菌條件下。無防腐劑的ondansetron和下列靜脈輸注液混合後，放置於室溫\(25℃以下\)的螢光燈下或冷藏，可維持安定達7天：Sodium Chloride IV Infusion BP 0.9%w/v; Glucose IV Infusion BP 5%w/v; Mannitol IV Infusion BP 10%w/v; Ringer IV Infusion; Potassium Chloride 0.3%w/v and Sodium Chloride 0.9%w/v IV Infusion BP; Potassium Chloride 0.3%w/v and Glucose5%w/v IV Infusion BP。 |

